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1. Materials and methods 
Polystyrene Fmoc protected Rink Amide resin (load 0.71 mmol/g) and Fmoc-L-Lys(Mtt)-OH 
were purchased from Iris.!Fmoc-L-Arg(Pbf)-OH, Fmoc-L-Leu-OH, glutaric anhydride, tert-
butyl carbazate, triisopropylsilane (TIS), Disopropylethyl amine (DIEA) were obtained from 
Sigma-Aldrich. Trifluoroethanol, 1,1,1,3,3,3-Hexafluoroisopropanol (HFIP) was purchased 
from TCI. Egg yolk L-α-phosphatidylcholine was purchased from Avanti Polar Lipids. 
Peptide synthesis grade N,N-dimethylformamide was purchased from Scharlau. All other 
chemicals were purchased from Sigma-Aldrich, TCI or Fisher.  
Lipofectamine 2000 was purchased from Life Technologies, Dulbecco’s Modified Eagle’s 
Medium (4500 mg/L glucose, L-glutamine, sodium pyruvate and sodium bicarbonate) was 
purchased from Gibco. 
The aldehydes tested were either commercially available or synthesized following reported 
protocols[1] from the corresponding alcohols. Boc protected adipic acid monohydrazine 2 was 
prepared as previously described.[2][3]  
A microwave assisted peptide synthesiser (Liberty Lite, CEM) was used to prepare the 
peptide according to standard methods developed by the manufacturers involving 
diisopropylcarbodiimide (DIC) 0.5 M in DMF as activator and 
ethyl(hydroxyimino)cyanoacetate (Oxyma) 1 M in DMF as activator base. 
High-performance liquid chromatography coupled with mass spectrometry (HPLC-MS) 
analyses were carried out on Agilent Technologies 1260 Infinity II equipped with a 6120 
Quadrupole LC-MS using an Agilent SB-C18 column with Solvent A:Solvent B gradients 
between 5:95 and 95:5 (Solvent A: H2O with 0.1 % TFA; Solvent B: CH3CN with 0.1 % 
TFA). High-performance liquid chromatography (HPLC) preparative purification was carried 
out on Waters 1525 provided with a binary pump with a dual wavelength Waters 2489 UV 
detector using a Phenomenex Luna C18(2) 100A column. A Jasco LC 4000 equipped with a 
quaternary pump and a photo diode array MD-4015 was used for semi-preparative 
purification using an Agilent Eclipse XDB-C18 column gradients between 95:5 and 25:75 
(Solvent A: H2O with 0.1 % TFA; Solvent B: CH3CN with 0.1 % TFA).  
Nuclear Magnetic Resonance (NMR) spectra were recorded on a Varian Mercury 300 MHz. 
Chemical shifts are reported in ppm referenced to the following solvent signals: HOD δ H 
4.79 and CDCl3 δ H 7.26 ppm, δ C 77.0 ppm. Spin multiplicities are reported as a singlet (s), 
doublet (d), triplet (t) with coupling constants (J) given in Hz, or multiplet (m). Accurate 
mass determinations (HR-MS) using ESI-MS were performed on a Bruker MicroTof mass 
spectrometer.  
Circular Dichroism (CD) measurements were performed with a Jasco J-1100 CD 
Spectrometer equipped with a Jasco MCB-100 Mini Circulation Bath for temperature control. 
For the acquisition of cell microscopy images an Andor Zyla 4.2 digital camera mounted on a 
Nikon Eclipse Ti-E epifluorescence microscope was used. 
A Tecan Infinite F200Pro microplate reader was used to measure fluorescence of cells 
expressing eGFP directly in Costar cell culture 96-well plates as well as UV-Vis absorbance 
for the viability assays. 
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Flow cytometry was performed on a Guava easyCyteTM cytometer. Data analysis was 
performed with InCyte software included in GuavaSoft 3.2 (Millipore). 
Dynamic Light Scattering (DLS) and zeta (ζ)  potential were acquired in a Malvern Nano ZS 
equipped with a HeNe laser (633 nm). Scattered light was detected at an angle of 90º. 
2. Abbreviations 
Aa: Amino acid; AFM: atomic force microscopy; Arg: Arginine; Boc: tert-Butoxycarbonyl; 
Calcd: Calculated; CD: circular dichroism; DCM: Dichloromethane; DIC: 
diisopropylcarbodiimide; DIEA: N,N-Diisopropylethylamine; DLS: dynamic light scattering; 
DMEM: Dulbecco's Modified Eagle Medium; DMF: N,N-Dimethylformamide; DMSO: 
Dimethylsulfoxide; ESI: electrospray ionization; Fmoc: N-Fluorenyl-9-methoxycarbonyl; 
eGFP: enhanced Green Fluorescent Protein; HFIP: 1,1,1,3,3,3-Hexafluoro-2-propanol; HKR: 
HEPES-Krebs-Ringer; HPLC: High-performance liquid chromatography; HRMS: High 
resolution mass spectrometry ; Leu: leucine; Lys: Lysine; Mtt: 4-Methyltrityl; MTT: 3-(4,5-
dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide; N-HATU: N-[(Dimethylamino)-1H-
1,2,3-triazolo[4,5-b]pyridin-1-ylmethylene]-N-methylmethanaminiun hexafluorophosphate 
N-oxide; N-HBTU: N-[(1H-Benzotriazol-1-yl)4(dimethylamino)methylene]-N-
methylmethanaminium hexafluorophosphate N-oxide; Pbf: 2,2,4,6,7-
Pentamethyldihydrobenzofuran-5-sulfonyl; PBS: Phosphate buffered saline; POPC: 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; RP: Reverse Phase; SPPS: Solid Phase 
Peptide Synthesis; TAE: tris-acetate-ethylenediaminetetraacetic acid; TEM: transmission 
electron microscopy; TFE: Trifluoroethanol; TIS: Triisopropylsilane. 
3. Peptide Synthesis 
P1 was synthesised either manually or by using an automated peptide synthesiser. In brief, 
Rink Amide resin (loading 0.71 mmol/g) was swollen in DMF (peptide synthesis grade, 2 
mL) for 20 min in a peptide synthesis vessel. Coupling cycles involved the removal of Fmoc 
protecting group with a solution of piperidine in DMF (20 %, 2 mL) for 10 min and then the 
mixture was filtered and the resin was washed with DMF (3 x 2 mL, 1 min). Then, a 
premixed solution in DMF of Fmoc-α-amino acid (4 equiv), N-HBTU (4 equiv) (2 mL) and 
DIEA (0.195 M solution in DMF, 4 equiv) was added to the resin under nitrogen stream for 
15 min. Finally, the resin was washed with DMF (3 x 2 mL, 1 min). The completion of each 
amino acid coupling and deprotection steps was monitored by TNBS test.[4]  
For automated synthesis, a variant of the previous protocol was used instead, according to 
manufacturer’s recommendations. 0.05 mmol of Rink Amide resin was placed into the 
peptide synthesiser reaction vessel, swollen in DMF, followed by cycles of Fmoc cleavage 
with piperidine 20% in DMF, washings (3x), then amino acid (5 equiv 2M amino acid 
solution in DMF), DIC (10 equiv) and Oxyma (10 equiv) were added into the reaction vessel 
and microwaved for 5 min under temperature control followed by washings (3x). All steps 
were performed under nitrogen atmosphere. After the linear peptide was finished the resin 
was transferred to a different reaction vessel to perform the peptide modification manually. 
3.1.  Hydrazide peptide modification 
Following peptide synthesis, solid phase N-terminus acetylation at 0.05 mmol scale with a 
mixture of acetic anhydride (Ac2O) and 2,6-lutidine (1:1, 1 mL) was carried out under 
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nitrogen stream for 30 min. The resin was washed with DCM (3x) prior to add a mixture of 
DCM/HFIP/TFE/TIS (6.5/2/1/0.5, 2 mL) to selectively cleave the lysine Mtt protecting 
groups. The suspension was mechanically stirred for 2 h followed by washings with DCM. 
After a second deprotection cycle, the resin was washed and subsequently swollen in DMF 
for 30 min. Then a solution of 2 (5 equiv) in DMF under nitrogen stream, followed by N-
HATU (5 equiv) in DMF and pure DIEA (8 equiv) was added dropwise. The reaction was 
stirred under nitrogen stream for 30 min and thoroughly washed with DMF. 
The modified peptide was cleaved from the solid support together with removal of protecting 
groups under strong acidic standard conditions: TFA/DCM/TIS/H2O (90/5/2.5/2.5) for 2 h 
and precipitated in Et2O. The suspension was centrifuged, the solid residue dissolved in 
H2O/CH3CN (1/1) and purified by preparative C18 reverse-phase HPLC [Phenomenex Luna 
C18(2) 100A column, H2O (0.1% TFA)/CH3CN (0.1% TFA) 95:5 (5 min), 95:5→25:75 
(5→35 min)] with a binary gradient of Solvent A and Solvent B. The corresponding fractions 
were freeze-dried to afford the pure peptide P1 as a white solid (11.2 mg, 11% yield). Purity 
and characterization were confirmed by analytical HPLC, mass spectrometry and 1H NMR 
(Figure S1). 1H NMR (300 MHz, D2O) δ (ppm): 4.50-4.13 (m, 13H), 3.35-2.90 (m, 16H), 
2.41-2.24 (m, 8H), 2.06 (s, 3H), 2.00-1.27 (m, 55H), 1.00-0.84 (m, 30H). MS (ESI, H2O/ 
CH3CN): 1209 (12, [M+2H+3TFA]2+), 1152 (13, [M+2H+2TFA]2+), 1095 (11, 
[M+2H+TFA]2+), 768 (37, [M+3H+2TFA]3+), 730 (100, [M+3H+TFA]3+), 692 (65, 
[M+3H]3+), 548 (19, [M+4H+TFA]4+), 519 (26, [M+4H]4+). HRMS (ESI): Calcd for 









Figure S1. 1H NMR spectrum (D2O, 300 MHz) of P1 (a), analytical RP-HPLC 
chromatogram: Rt 12.3 min [Agilent SB-C18 column, H2O (0.1% TFA)/ CH3CN (0.1% TFA) 
95:5→25:75 (0→21 min) (b), ESI-MS traces of P1. 1209 (12, [M+2H+3TFA]2+), 1152 (13, 
[M+2H+2TFA]2+), 1095 (11, [M+2H+TFA]2+), 768 (37, [M+3H+2TFA]3+), 730 (100, 
[M+3H+TFA]3+), 692 (65, [M+3H]3+), 548 (19, [M+4H+TFA]4+), 519 (26, [M+4H]4+). 
 
4. Preparation of amphiphiles 
P1 was mixed with 4 equiv of aldehyde tail (2 equiv per hydrazide) in a mixture of 
DMSO/ultrapure water/AcOH (4.75/4.75/0.5) and shaked at 60 ºC for 2h. For instance, 25 µl 
of P1 (2.5 mM in ultrapure water) were mixed with 25 µl of 10 mM hydrophobic aldehyde 
tail in DMSO containing 10% AcOH. The mixture was stirred at 60 ºC for 2 h, and the 
resulting dihydrazones P1Tx were then used for DNA activation experiments. Amphiphile 
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formation was checked by HPLC, and confirmed by ESI-MS (Figure S2). Unless otherwise 
stated, reactions proceeded at 1.25 mM peptide final concentration in all cases before further 
dilutions. 
 
Figure S2. Analytical RP-HPLC chromatogram of crude P1T20 Rt 5.9 min [Agilent SB-C18 
column, H2O (0.1% TFA)/ CH3CN (0.1% TFA) 95:5→5:95 (0→5 min), 5:95 (1 min) (a). 
Residual signals corresponding to P1 (Rt 3.8 min) and monofunctionalised peptide (marked 
with an asterisk, Rt 4.8 min) are also depicted. ESI-MS traces of P1T20. 803 (1, 64, 
[M+3H]3+), 841 (2, 100, [M+3H+TFA]3+), 879 (3, 29, [M+3H+2TFA]3+), 1204 (4, 6, 
[M+2H]2+), 1261 (5, 14, [M+2H+TFA]2+), 1318 (6, 21, [M+2H+2TFA]2+), 1375 (7, 16, 
[M+2H+3TFA]2+). 
 
Due to signal saturation, DMSO was substituted by CH3CN for CD experiments and the 
acetic acid concentration was reduced to a 1% total volume. 
 
5. DNA transfection screening 
In a 96 well plate, HeLa cells seeded one day before (50000 cells/mL, 100 µL/well) and 
incubated at 37 ºC/ 5% CO2/ 95% humidity in an INCO 108 incubator (Memmert) with 
Dulbecco’s Modified Eagle’s Medium (4500 mg/L glucose, L-glutamine, sodium pyruvate 
and sodium bicarbonate), supplemented with 10% foetal bovine serum and 1% of Penicillin-
Streptomycin-Glutamine Mix (Fisher). 
Freshly prepared peptide amphiphiles were diluted with Dulbecco’s Modified Eagle’s 
Medium (DMEM) until concentrations of 50, 25, 5 and 2.5 µM. Plasmid encoding for eGFP 
(pEGFP-C1, Clontech) containing 4731 bp (320 µg/mL in water) was diluted with DMEM 
until 10 µg/mL. Described peptide amphiphile solutions were mixed with equal volumes of 
plasmid solution (typically 15 µL each) in triplicate in a 96 well plate and incubated at room 
temperature for 30 min, reaching the charge ratios (+/-) of 10, 5, 1, 0.5. Lipofectamine 2000 
was also incubated with the plasmid for the same time. Then, 20 µL of every peptide 
amphiphile/plasmid mixture was added to HeLa cells previously covered with 30 µL of 
DMEM without FBS or antibiotics. Final peptide amphiphile concentrations were 10, 5, 1 
and 0.5 µM and every well contained 2 ng/µL (100 ng/well) of plasmid (except control 
untreated cells). Positive controls contained 330 ng of Lipofectamine 2000 per well. Cells 
were incubated for 4 h prior to exchange the medium for DMEM containing 10% bovine 
foetal serum and 1% of Penicillin-Streptomycin-Glutamine Mix. 
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After 72 h, the medium was replaced by PBS (137 mM NaCl; 2.7 mM KCl; 8 mM Na2HPO4, 
1.5 mM KH2PO4, pH 7.4) buffer and the fluorescence intensity was recorded with a Tecan 
plate reader (λexc=485, λem=535 nm). Four measurements per well were averaged. 
Fluorescent cells were also visualised and confirmed by epifluorescence microscope.  
 
6. Dose-response experiments 
Optimal peptide amphiphile/plasmid charge ratio (10 or 5) for the hit candidates obtained 
from transfection screening were used for dose-response experiments.  
Freshly prepared peptide amphiphiles were diluted with Dulbecco’s Modified Eagles 
Medium (DMEM) until concentrations of 50 µM. Plasmid was diluted with DMEM until 40 
or 20 µg/mL (to reach 5 and 10 +/- charge ratio respectively). Peptide amphiphile solutions 
were mixed with equal volumes of plasmid solution (typically 100 µL each) and incubated 
for 30 min at room temperature prior to prepare the following dilutions with DMEM: 25, 
12.5, 6.25, 2.5 µM of peptide amphiphiles. 20 µL of these solutions were added to HeLa cells 
previously covered with 30 µL of DMEM. Final peptide amphiphile concentrations were 10, 
5, 2.5 and 1 µM. The cells were incubated for 4 h before exchanging the medium for DMEM 
containing 10% bovine foetal serum and 1% of Penicillin-Streptomycin-Glutamine Mix. 
After 72 h, the medium was replaced by PBS buffer and the fluorescence intensity was 
recorded with a Tecan plate reader (λexc=485, λem=535 nm). Four measurements per well 
were averaged. Fluorescent cells were also visualised and confirmed by epifluorescence 
microscope.  
 
7. Flow cytometry 
HeLa cells were transfected with pEGFP-C1 plasmid by mixing equal volumes of 25 µM of 
P1T25 freshly prepared and plasmid diluted until 20 µg/mL in DMEM. 20 µL of this solution 
was added to HeLa cells with 30 µL of DMEM (final concentration 5 µM, charge ratio 5 
charge +/- ratio. Controls with only plasmid (200 ng/well) or with Lipofectamine 2000 (330 
ng of Lipofectamine 2000 and 200 ng/well) were also prepared. After 4 h, transfection 
mixtures were replaced by 100 µL of DMEM supplemented with 10 % FBS and 1 % 
Penicillin-Streptomycin-Glutamine Mix. Three days after transfection, cells were washed 
with PBS, trypsinised with 50 µL of Trypsin-EDTA (Gibco) for 10 min at 37 ºC, and trypsin 
neutralized with 150 µL of 5 % FBS in PBS with 5 mM EDTA. Cell clumps were broken by 
pipetting before analyzing on a Guava easyCyteTM cytometer. GFP levels were determined by 
excitation at 488 nm and detection at 512/18 nm. For the analysis, cells with typical FSC and 
SSC parameters were selected, and cells were considered GFP positive when fluorescence 
signal was higher than that of the untreated control. Data analysis was performed with InCyte 
software included in GuavaSoft 3.2 (Millipore). 
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Figure S3. Flow cytometry analysis of transfected cells. Dot plots showing forward and side-
scatter channels of untreated cells, cells transfected with pEGFP-C1 using 5 µM P1T25, or 
cells transfected with Lipofectamine 2000 (a). The region gated for further analysis is shown 
in red (R1), and GFP positive cells are shown as green dots. Dot plots of the same samples, 
plotting GFP fluorescence versus the side-scatter channel (b). Histogram of GFP fluorescence 
of the same samples, showing the region selected as GFP-positive cells for the analysis (c). 
Percent of GFP positive cells in untreated cells (U), cells incubated with the plasmid alone 
(P), and cells transfected with peptide P1 conjugated with oleic aldehyde (P1T25) or 
Lipofectamine (L). Red dots indicate the cell concentration of the samples. The mean and SD 
of three replicates are shown (d). 
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8. DLS and ζ potential 
Freshly prepared peptide amphiphiles P1T20 and P1T25 were mixed with the plasmid at 10 
charge +/- ratio with filtered (Nylon, 0.45 µM) ultrapure water at an amphiphile 
concentration of 25 µM. The mixture was incubated for 30 min at room temperature prior to 
be transferred to a standard disposable cuvette for size measurements. ζ potential 
measurements were performed in Malvern disposable cuvettes for ζ potential applying the 
Smoluchovsky model by the instrument software. All experiments were done in triplicate at 
25 oC (Figure S4). 
 
Figure S4. Hydrodynamic diameter size distribution and correlation curves for P1T25 (a, b) 
and P1T20 (c, d) in the presence and in the absence of DNA plasmid. In both cases the 
hydrodynamic diameter is decreased in the presence of plasmid DNA and P1T20 complex 
shows a broader size distribution. All experiments are depicted in triplicate. PDI stands for 
polydispersity index. 
A variant of the previous experiment was performed as assessment of complex stability: A 
solution of P1 in ultrapure water and freshly prepared peptide amphiphiles P1T20 and P1T25 
were mixed with the plasmid at 10 charge +/- ratio with filtered (Nylon, 0.45 µM) PBS pH 
7.2 or citrate buffer 100 mM pH 5.9 at a peptide/amphiphile concentration of 25 µM. After 
30 min of incubation at room temperature, the mixtures were transferred to standard 
disposable cuvettes for size measurements. Measurements were performed in triplicate at the 
times indicated in Figure S5. 
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Figure S5. Lipoplex size diameters against the time for P1T20, P1T25 and the parent peptide 
P1 in PBS pH 7.2 (a) and citrate buffer 100 mM, pH 5.9 (c). The respective polydispersity 
indexes (PDI) are also depicted (b and d respectively). Data shows an increased aggregation 
of material for P1T20, P1T25 within time together with a loss of particle definition (increase 
of PDI). Inactive P1 particles do not show the same behaviour. All measurements were 
performed in triplicate. Error bars represent standard deviation. 
 
9. Atomic Force Microscopy (AFM) 
Freshly prepared peptide amphiphiles P1T20 and P1T25 were mixed with the plasmid at 10 
charge +/- ratio at an amphiphile concentration of 25 µM in PBS. The mixture was incubated 
for 30 min and subsequently pipetted onto freshly cleaved mica discs (Grade V-1 Muscovite). 
After 10 min, the excess was removed, the mica surface thoroughly washed with ultrapure 
water, and dried under a nitrogen flow. Standard AFM measurements were conducted under 
ambient atmosphere at room temperature using a XE-100 instrument (Park Systems 
Corporation) in non-contact mode by using ACTA cantilevers (300 kHz nominal frequency 
and 37 N/m nominal spring constant). 10x10 µm images were acquired at a scanning speed of 
0.5 Hz (Figure S6). 
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Figure S6. AFM images, including topographic profiles (blue lines) of P1T25 (a) and P1T20 
(b) lipoplexes with eGFP plasmid on mica (25 mM). Measured diameters were 57.8 ± 0.9 and 
101.2 ± 36.4 nm respectively, in close agreement with DLS measurements. 
 
10. Transmission Electron Microscopy (TEM) 
Freshly prepared peptide amphiphiles P1T20 and P1T25 were mixed with the plasmid at 10 
charge +/- ratio at an amphiphile concentration of 25 µM in PBS. The mixture was incubated 
for 30 min and subsequently pipetted onto carbon coated copper grids. After 10 min, the 
remaining solution was removed with filter paper, thoroughly washed with ultrapure water. 
Staining was carried out by dispensing 10 µL of a solution of phosphotungstic acid (2% in 
water) on top of the grids, removed after 1 min and thoroughly washed with ultrapure water. 
Micrographs were acquired on a JEOL JEM 2010 transmission electron microscope operating 
at 200 kV accelerating voltage (Fig. S7). 
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Figure S7. TEM micrographs of P1T25 (a) and P1T20 (b) lipoplexes with eGFP plasmid (25 
mM). Details of individual complexes are depicted in the insets. 
 
11. Gel retardation assay 
Freshly prepared peptide amphiphiles P1T20 and P1T25 were mixed with the plasmid at 10, 5, 
1, 0.5, 0.05, 0.01 charge +/- ratio (fixed plasmid concentration of 5 ng/µL) and incubated at 
room temperature for 30 min. The mixtures, including a solution of the unmodified plasmid 
at the same concentration, were loaded into a 0.8% agarose gel containing ethidium bromide 
with tris-acetate-ethylenediaminetetraacetic acid (TAE) buffer. Electrophoresis was 
performed at 100 V for 15 min. 
 
12. Viability assays 
In a 96 well plate, HeLa cells (50000 cells/mL, 100 µL/well) were incubated at 37 ºC/ 5% 
CO2/ 95 % humidity with Dulbecco’s Modified Eagle’s Medium (4500 mg/L glucose, L-
glutamine, sodium pyruvate and sodium bicarbonate), supplemented with 10% foetal bovine 
serum and 1% of Penicillin-Streptomycin-Glutamine Mix.  
Freshly prepared peptide amphiphiles were diluted with DMEM until concentrations of 50 
µM. The procedure followed for Dose-response experiments (see section 7) was reproduced. 
The cells were incubated with the complexes for 4 h prior to exchange the medium by 
DMEM containing 10% bovine foetal serum and 1% of Penicillin-Streptomycin-Glutamine 
Mix. 
After 72 h, the medium was replaced by fresh medium (100 µL) and 10 µL of the water 
soluble 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide[5] (MTT) reagent (5 
mg/mL stock solution in PBS) was used to assess cell viability. Viable cells are capable of 
reducing MTT to insoluble formazan by their metabolic activity. After incubation at 37 oC for 
4 h, the medium was aspirated and the purple precipitate was dissolved with DMSO (100 
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µL/well). Absorbance at 570 nm was measured in a Tecan plate reader. Values were 
normalised against untreated cells. 
 
13. Circular Dichroism 
Spectra were acquired in a Jasco 1100 at 100 µM peptide amphiphile concentration both in 
trifluoroethanol or aqueous HEPES-Krebs-Ringer (HKR) buffer (5 mM HEPES, 137 mM 
NaCl, 2.68 mM KCl, 2.05 mM MgCl2, 1.8 mM CaCl2, pH 7.4). The acquisition range was 
300-190 nm, at a scanning speed of 200 nm/min (1.0 nm band width, 1 nm data pitch, 3 
accumulations). Measurements were done from 10 ºC to 60 ºC at 10 ºC intervals in a quartz 
cell of 0.2 cm path length (Figure S8).  
For the measurements in liposomes, samples were prepared by mixing egg yolk L-
phosphatidylcholine (100 mg/mL solution in CHCl3) with the peptide (100 µM) in TFE to 
obtain a lipid/peptide ratio of 18:1 in a 10 mL round bottomed flask. The mixture was 
concentrated in a rotary evaporator to dryness, forming a film. Lipid-peptide mixture was 
suspended in HKR buffer to a final peptide concentration of 100 µM followed by sonication 
for 45 min.  
The results expressed as the mean residue molar ellipticity [θ]MRt with units of 
mdeg·cm2·dmol-1 were calculated using the following equation (Eq. S1). 
[θ]MRt = !""×!!×!×!       Eq S1 
where θ is the ellipticity (mdeg), C is the peptide concentration (M), l is the cell path length 
(cm) and N is the number of residues. 
The percentage of α-helix was calculated using the mean residue molar ellipticity [θ]MRt at 
222 nm as follows (Eq. S2).  
%!!!ℎ!"#$ = ! [!]!!!!!"#$!"!"" ×!100     Eq S2 
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Figure S8. Circular Dichroism spectra at different temperatures of P1T20 (a), P1T25 (b), 
P1T27 (c) and P1 (d) in TFE (left), HKR buffer (middle) and in the presence of liposomes (d). 
The percentage of α-helix was calculated at every temperature by applying Eq S2 and results 
are presented from higher to lower temperature.  
 
14.  Computational methods 
The starting geometry of the helical natural peptide P1 was constructed with Avogadro 
package[6,7]. The non-standard oleic containing residue was added to the .rtp file in Gromos96  
54a7 force field using the parameters obtained from the ATB server[8] and the natural peptide 
P1 was directly mutated to P1T25 using GROMACS utilities. Both peptides were simulated 
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in water and in a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) bilayer using 
the same force field. The simulations were performed with the GROMACS 5.0[9] Molecular 
Dynamics program. After neutralizing the systems adding Cl- ions, several simulations were 
carried out: i) P1T25 in a water box during 30 ns (Figure 7A), ii) P1 and P1T25 inserted into a 
POPC bilayer (50ns, Figures 7B, 7E, 7F) and iii) the structure of P1T25 obtained from 
simulation i) horizontally oriented with respect to the POPC bilayer, during 50 ns in presence 
and absence of an electric membrane z-potential (0.01 V/nm),  (Figure 7C). The simulations 
in the membrane were carried out in presence of 0.1 M NaCl concentration. All systems were 
partially optimized, thermalized, and equilibrated, followed by unrestrained simulations (time 
step = 2 fs) for each of the systems studied. The constant pressure and temperature NPT 
ensemble was employed with a pressure of 1 bar controlled using a isotropic (simulations in 
water) or semi-isotropic (simulations in the membrane) Parrinello–Rahman barostat[10], and a 
temperature of 300 K imposed by a V-rescale thermostat temperature coupling using velocity 
rescaling with a stochastic term)[11] The LINCS[12] algorithm was employed to remove the 
bond vibrations. The Particle Mesh Ewald method[13] coupled to periodic boundary 
conditions was used to treat the long-range electrostatics using a direct-space cut-off of 1.0 
nm. The van der Waals interactions were computed using PBC coupled to a spherical cut-off 
of 1.4 nm. Data were analysed using GROMACS and locally written code. Molecular graphic 
images were prepared using visual molecular dynamics (VMD).[14]  
 
 
Figure S9: Detail of the lipids around the P1T25 from its simulation inserted into a POPC 
bilayer, after 50ns. 
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